Profarma Distribuidora de Produtos Farmaceuticos SA
BOVESPA:PFRM3

Watchlist Manager
Profarma Distribuidora de Produtos Farmaceuticos SA Logo
Profarma Distribuidora de Produtos Farmaceuticos SA
BOVESPA:PFRM3
Watchlist
Price: 7.67 BRL -0.39%
Market Cap: 949.6m BRL

Profitability Summary

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Past Growth

Analyzing past growth in Revenue, Operating Income, and Net Income allows investors to assess the company's profitability and operational efficiency. Consistent improvement in these metrics typically signals long-term strength and stability.

Show More Less

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Show More Less

Earnings Waterfall
Profarma Distribuidora de Produtos Farmaceuticos SA

Revenue
10.6B BRL
Cost of Revenue
-9B BRL
Gross Profit
1.6B BRL
Operating Expenses
-1.3B BRL
Operating Income
304.1m BRL
Other Expenses
-179.6m BRL
Net Income
124.5m BRL

Margins Comparison
Profarma Distribuidora de Produtos Farmaceuticos SA Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
BR
Profarma Distribuidora de Produtos Farmaceuticos SA
BOVESPA:PFRM3
933.1m BRL
15%
3%
1%
US
Mckesson Corp
NYSE:MCK
89.1B USD
4%
1%
1%
US
Cencora Inc
NYSE:COR
56.5B USD
3%
1%
1%
US
Amerisourcebergen Corp
LSE:0HF3
56.1B USD
3%
1%
1%
US
Cardinal Health Inc
NYSE:CAH
37.7B USD
4%
1%
1%
AU
Sigma Healthcare Ltd
ASX:SIG
33.8B AUD
7%
0%
0%
CN
Huadong Medicine Co Ltd
SZSE:000963
78.7B CNY
33%
11%
8%
CN
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
71.7B CNY
11%
3%
2%
KR
Celltrion Healthcare Co Ltd
KOSDAQ:091990
12.2T KRW
30%
9%
7%
US
Henry Schein Inc
NASDAQ:HSIC
8.6B USD
32%
6%
3%
AU
EBOS Group Ltd
OTC:EBOSY
8.2B USD
13%
4%
2%

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Show More Less

Return on Capital Comparison
Profarma Distribuidora de Produtos Farmaceuticos SA Competitors

Country Company Market Cap ROE ROA ROCE ROIC
BR
Profarma Distribuidora de Produtos Farmaceuticos SA
BOVESPA:PFRM3
933.1m BRL
10%
2%
12%
10%
US
Mckesson Corp
NYSE:MCK
89.1B USD
-163%
5%
31%
24%
US
Cencora Inc
NYSE:COR
56.5B USD
162%
3%
20%
14%
US
Amerisourcebergen Corp
LSE:0HF3
56.1B USD
162%
3%
20%
14%
US
Cardinal Health Inc
NYSE:CAH
37.7B USD
-50%
3%
21%
15%
AU
Sigma Healthcare Ltd
ASX:SIG
33.8B AUD
-2%
-1%
2%
-3%
CN
Huadong Medicine Co Ltd
SZSE:000963
78.7B CNY
16%
10%
19%
14%
CN
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
71.7B CNY
6%
2%
9%
5%
KR
Celltrion Healthcare Co Ltd
KOSDAQ:091990
12.2T KRW
7%
3%
9%
5%
US
Henry Schein Inc
NASDAQ:HSIC
8.6B USD
12%
4%
10%
6%
AU
EBOS Group Ltd
OTC:EBOSY
8.2B USD
10%
4%
11%
8%

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

Show More Less